Research on citrus plants is the result of increasing interest in the discovery of plant species with potential insect‐repellent properties. Insect‐repelling ability can be achieved by the numerous ubiquitous citrus species. This is mainly due to the presence of phytochemicals such as limonene, citronellol, citral, and α‐pinene. These phytochemicals’ composition varies depending on the geographical location of the plant. The extraction method dictates the configuration of attainable phytochemicals while the dosage affects the repellency potential. Therefore, developing insect repellent involved a number of observations related to the identification of both citrus plant phytochemical composition present in the different parts of the plant and the repellency potential of these phytochemicals in advance. Conversely, the development of repellent methods that go beyond conventional methods has been made possible by scientific developments including modern strategies such as encapsulation, the preparation of emulsion, and the incorporation of repellents into textiles. Therefore, this review article intends to probe into the aforementioned information and provide a sound insight into citrus‐based repellent development in the future.
1 July 2016 in Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology
Dengue virus is a serious public health issue in tropical and subtropical regions. The global incidence of dengue necessitates the potent antiviral medication for the prevention of proliferation of the virus inside the human body. The DEN2 NS2B/NS3 protease, present in the dengue virus, is an attractive drug target due to its essential role in viral replication, survival, and other cellular activities. In traditional medicine, Carica papaya leaves have been used for the treatment of dengue fever in Sri Lanka, Pakistan, and Malaysia. Therefore, phytochemicals present in Carica papaya leaves have a potential anti-viral activity, and could be used as strong drug candidates against the dengue virus. In this investigation, two phytochemical compounds in Carica papaya leaves, 5,7-dimethoxycoumarin and p-coumaric acid, were selected from the literature and then docked against the DEN2 NS2B/NS3 protease. The compounds showed strong interactions with favorable binding energies in the active site of DEN2 NS2B/NS3 protease. To validate the molecular docking results, the docked ligand–protein complexes were subjected to molecular dynamic simulation along with the apo form of the protein for 30 ns. The molecular dynamic simulation analysis comprising root mean square deviation and fluctuation, the radius of gyration, hydrogen bonding, the Dictionary of Secondary Structure of Proteins (DSSP), and MM/PBSA, revealed the stability of the apo and complex systems. Interactions formed by these compounds with residues Leu149 and Asn152 were found to be essential for the stability of the ligand–protein complex. The findings revealed that these phytochemical compounds depict the promising results against the DEN2 serotype of the dengue virus and the potential for therapeutic drugs. Further experimentation on the proposed compounds is necessary to validate the results and could lead to the development of strong inhibitors with improved activity.
28 January 2025 in Biochemical and Biophysical Research Communications
Tumor necrosis factor (TNF) related apoptosis-inducing ligand (TRAIL) is a TNF superfamily cytokine primarily acknowledged for its ability to selectively induce apoptosis in cancer cells. Beyond its antitumor effects, recent literature emphasizes the pleiotropic functions of TRAIL in physiological states and acute/chronic non-malignant diseases indicating its potential to be a breakthrough in diagnostics. This review explores the current understanding of the dynamic role of circulating soluble TRAIL (sTRAIL) and its potential as both a diagnostic and prognostic marker. Multiple in vitro, in vivo, and clinical studies in a wide range of neoplastic and non-neoplastic diseases including infectious diseases have been carried out to explore the potential role of sTRAIL in disease pathogenesis and as well as the possibilities of using it as a diagnostic and prognostic marker. The expression of sTRAIL seems to be context-dependent suggesting further research, particularly towards establishing disease-specific cutoff values. However, the lack of standardization in the serum sTRAIL estimation and the absence of reference intervals remain significant barriers to its clinical application. Addressing these challenges is essential for using circulating sTRAIL as an accurate diagnostic and prognostic marker in clinical practice.